P. Delafontaine

发表

A pharmacogenetic versus a clinical algorithm for warfarin dosing.

R. Califf, Jeffrey L. Anderson, N. Geller, 2013, The New England journal of medicine.

Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study.

Anna C. Porter, H. Feldman, R. Townsend, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Mechanisms of Cardiac Hypertrophy and the Development of Heart Failure

P. Delafontaine, M. Brink, Yao‐Hua Song, 2004 .

In‐vivo measurements of wall shear stress in human coronary arteries

P. Doriot, P. Chatelain, P. Delafontaine, 2000, Coronary artery disease.

Technique and Imaging for Transthoracic Echocardiography of the Laboratory Pig

P. Delafontaine, E. K. Kerut, K. Pinkernell, 2004, Echocardiography.

Angiotensin II as candidate of cardiac cachexia

P. Delafontaine, M. Akao, 2006, Current opinion in clinical nutrition and metabolic care.

Effect of Hurricane Katrina on the Incidence of Acute Coronary Syndrome at a Primary Angioplasty Center in New Orleans

P. Delafontaine, S. Srivastav, S. Gautam, 2009, Disaster Medicine and Public Health Preparedness.

WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.

A. J. Valente, P. Delafontaine, B. Venkatesan, 2010, Cellular signalling.

The therapeutic potential of IGF-I in skeletal muscle repair

P. Delafontaine, M. Godard, Yao‐Hua Song, 2013, Trends in Endocrinology & Metabolism.

IGF-I in animal models of muscle wasting , neuromuscular disorders and injury Sarcopenia

P. Delafontaine, M. Godard, Yao‐Hua Song, 2013 .

Angiotensin II Modulation of Insulin-like Growth Factor I Expression in the Cardiovascular System.

P. Delafontaine, M. Brink, J. Du, 1996, Trends in cardiovascular medicine.

Transcriptional regulation of the insulin-like growth factor-I receptor gene: evidence for protein kinase C-dependent and -independent pathways.

P. Delafontaine, J. Du, X. Meng, 1996, Endocrinology.

Angiotensin II, Oxidative Stress and Skeletal Muscle Wasting

P. Delafontaine, Y. Higashi, Tadashi Yoshida, 2011, The American journal of the medical sciences.

Enhancing Repair of the Mammalian Heart

N. Rosenthal, P. Delafontaine, L. Monassier, 2007, Circulation research.

Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy.

A. J. Valente, P. Delafontaine, B. Venkatesan, 2011, Journal of molecular and cellular cardiology.

Coronary Angiographic Significance of Hyperacute St-T Changes Associated with Regadenoson Stress

P. Delafontaine, L. A. Howell, Thomas A. Turnage, 2013, Proceedings.

IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting.

W. Mitch, P. Delafontaine, Zhaoyong Hu, 2009, Journal of the American Society of Nephrology : JASN.

THE EFFECTS OF A GROWTH HORMONE-RELEASING HORMONE ANTAGONIST AND A GASTRIN-RELEASING PEPTIDE ANTAGONIST ON INTIMAL HYPERPLASIA OF THE CAROTID ARTERY AFTER BALLOON INJURY IN A DIABETIC RAT MODEL

P. Delafontaine, A. Schally, S. Srivastav, 2013 .

Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.

S. N. Murthy, A. J. Valente, P. Delafontaine, 2012, American journal of physiology. Heart and circulatory physiology.

Bortezomib inhibits C2C12 growth by inducing cell cycle arrest and apoptosis.

P. Delafontaine, M. Godard, Y. H. Song, 2014, Biochemical and biophysical research communications.

IGF-1, oxidative stress and atheroprotection

P. Delafontaine, Y. Higashi, S. Sukhanov, 2010, Trends in Endocrinology & Metabolism.

Predictors of left ventricular dilatation in young adults (from the Bogalusa Heart Study).

P. Delafontaine, S. Srinivasan, G. Berenson, 2005, The American journal of cardiology.

Angiotensin II activation of insulin-like growth factor 1 receptor transcription is mediated by a tyrosine kinase-dependent redox-sensitive mechanism.

T. Peng, P. Delafontaine, J. Du, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Vitamin C and percutaneous coronary intervention.

P. Delafontaine, A. Anwar, 2010, JACC. Cardiovascular interventions.

Rapid estrogen receptor-α signaling mediated by ERK activation regulates vascular tone in male and ovary-intact female mice.

P. Delafontaine, K. Yin, M. Hamblin, 2018, American journal of physiology. Heart and circulatory physiology.

Endovascular stent-graft repair of ascending aortic dissection with a commercially available thoracic endograft.

P. Delafontaine, K. Atianzar, A. Sam, 2014, The Annals of thoracic surgery.

Nonsteroidal anti-Inflammatory drugs and cardiovascular risk.

P. Delafontaine, P. Howard, 2004, Journal of the American College of Cardiology.

Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin.

A. J. Valente, P. Delafontaine, B. Chandrasekar, 2013, Cellular signalling.

Multiomics Approach Reveals an Important Role of BNIP3 in Myocardial Remodeling and the Pathogenesis of Heart Failure with Reduced Ejection Fraction

P. Delafontaine, Todd W. Markowski, LeeAnn Higgins, 2022, Cells.

Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.

W. Mitch, P. Delafontaine, Y. Higashi, 2013, The international journal of biochemistry & cell biology.

Mechanisms of Cachexia in Chronic Disease States.

P. Delafontaine, Tadashi Yoshida, 2015, The American journal of the medical sciences.

Thiazolidinediones Up-regulate Insulin-like Growth Factor-1 Receptor via a Peroxisome Proliferator-activated Receptor γ-Independent Pathway*

P. Delafontaine, Y. Higashi, K. Holder, 2010, The Journal of Biological Chemistry.

THE RENIN-ANGIOTENSIN SYSTEM AND THE BIOLOGY OF SKELETAL MUSCLE: MECHANISMS OF MUSCLE WASTING IN CHRONIC DISEASE STATES.

P. Delafontaine, Tadashi Yoshida, 2016, Transactions of the American Clinical and Climatological Association.

Angiotensin Type 2 Receptor Signaling in Satellite Cells Potentiates Skeletal Muscle Regeneration*

P. Delafontaine, Tadashi Yoshida, Tashfin S. Huq, 2014, The Journal of Biological Chemistry.

Regeneration Proliferation and Prevents Skeletal Muscle Angiotensin II Inhibits Satellite Cell

P. Delafontaine, Z. Yablonka-Reuveni, B. Rezk, 2013 .

Angiotensin II Inhibits Satellite Cell Proliferation and Prevents Skeletal Muscle Regeneration*

P. Delafontaine, Z. Yablonka-Reuveni, B. Rezk, 2013, The Journal of Biological Chemistry.

Authors' Reply

P. Delafontaine, Zhen Lin, Xiao-Ming Yin, 2021, The Journal of Molecular Diagnostics.

IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.

P. Delafontaine, Tadashi Yoshida, S. Sukhanov, 2010, American journal of physiology. Heart and circulatory physiology.

β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.

A. J. Valente, P. Delafontaine, B. Chandrasekar, 2012, Journal of molecular and cellular cardiology.

Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy

P. Delafontaine, Tadashi Yoshida, 2020, Cells.

Mitochondrial Pathobiology and Metabolic Remodeling in Progression to Overt Systolic Heart Failure

T. LeJemtel, P. Delafontaine, A. Chaanine, 2020, Journal of clinical medicine.

Angiotensin II Infusion Induces Marked Diaphragmatic Skeletal Muscle Atrophy

P. Delafontaine, B. Rezk, Y. Higashi, 2012, PloS one.

Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus.

P. Delafontaine, Tadashi Yoshida, D. Kapusta, 2012, Endocrinology.

TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis

A. J. Valente, P. Delafontaine, S. S. Sakamuri, 2016, Molecular and Cellular Endocrinology.

Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E–Deficient Mice

P. Delafontaine, R. Korthuis, Z. Li, 2016, Circulation.

Insulin-Like Growth Factors, Cardiovascular Risk Factors, and Cardiovascular Disease

P. Delafontaine, I. Bolad, 2009 .

Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1.

A. J. Valente, P. Delafontaine, B. Chandrasekar, 2012, Cellular signalling.

Multi-Omics Approach Proﬁling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure

L. Navar, P. Delafontaine, Todd W. Markowski, 2021 .

EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB andMKK7/JNK/AP-1 signaling.

A. J. Valente, P. Delafontaine, B. Venkatesan, 2010, Journal of molecular and cellular cardiology.

Acetylsalicylic Acid Inhibits IL‐18‐Induced Cardiac Fibroblast Migration Through the Induction of RECK

A. J. Valente, P. Delafontaine, B. Chandrasekar, 2014, Journal of cellular physiology.

TRAF3IP2 mediates atherosclerotic plaque development and vulnerability in ApoE(-/-) mice.

P. Delafontaine, B. Chandrasekar, Y. Higashi, 2016, Atherosclerosis.

Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation.

A. J. Valente, P. Delafontaine, B. Venkatesan, 2010, American journal of physiology. Heart and circulatory physiology.

EMMPRIN activates multiple transcription factor pathways in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF- κ B and MKK7/JNK/AP-1 signaling

A. J. Valente, P. Delafontaine, B. Venkatesan, 2011 .

Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis.

P. Delafontaine, C. Bowers, Y. Higashi, 2009, Endocrinology.

Low circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice.

P. Delafontaine, C. Rosen, Y. Higashi, 2011, American journal of physiology. Heart and circulatory physiology.

The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension.

P. Delafontaine, T. Giles, L. Roffidal, 2011, Journal of the American Society of Hypertension : JASH.

Ct Values Do Not Predict Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmissibility in College Students

P. Delafontaine, R. Garry, Tony Y. Hu, 2021, The Journal of Molecular Diagnostics : JMD.

Abstract 13854: Micro-RNA Regulation of Collagen Production by Vascular Smooth Muscle Cells Mediated by La Ribonucleoprotein Domain Family Member 6: Potential Mechanisms Underlying Stable Phenotype of Atherosclerotic Plaque by Insulin-like Growth Factor 1

P. Delafontaine, Y. Higashi, Z. Li, 2016 .

Insulin-like growth factor 1 reduces coronary atherosclerosis in pigs with familial hypercholesterolemia

P. Delafontaine, J. Kolls, J. Jenkins, 2022, bioRxiv.

G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells: thrombin- and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor.

P. Delafontaine, M. Marrero, J. Du, 1996, Biochemical and biophysical research communications.

Regulation of Vascular Smooth Muscle Cell Insulin-like Growth Factor I Receptors by Phosphorothioate Oligonucleotides. EFFECTS ON CELL GROWTH AND EVIDENCE THAT SENSE TARGETING AT THE ATG SITE INCREASES RECEPTOR EXPRESSION (*)

P. Delafontaine, J. Du, P. Delafontaine, 1995, The Journal of Biological Chemistry.

Angiotensin II Type 2 Receptor Potentiates Skeletal Muscle Satellite Cell Differentiation via the GSK3β/β-catenin Pathway AT2R regulates GSK3β signaling in satellite cells

P. Delafontaine, B. Chandrasekar, T. Yoshida, 2022 .

Endothelial Deficiency of Insulin-like Growth Factor -1 Receptor Reduces Endothelial Barrier Function and Promotes Atherosclerosis in Apoe-Deficient Mice.

P. Delafontaine, R. Korthuis, Z. Li, 2020, American journal of physiology. Heart and circulatory physiology.

The ubiquitin ligase Nedd4 mediates oxidized low-density lipoprotein-induced downregulation of insulin-like growth factor-1 receptor.

P. Delafontaine, S. Parthasarathy, Y. Higashi, 2008, American journal of physiology. Heart and circulatory physiology.

The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin‐II‐Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4

A. J. Valente, P. Delafontaine, B. Chandrasekar, 2016, Journal of cellular physiology.

Lipid Management Strategies for the Prevention of Adverse Cardiovascular Events

P. Delafontaine, Brian C. Weiford, 2002, Heart Drug.

Natural disasters and myocardial infarction: the six years after Hurricane Katrina.

P. Delafontaine, S. Srivastav, S. Tiwari, 2014, Mayo Clinic proceedings.

Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease.

Mahboob Rahman, L. Appel, M. Keane, 2016, JAMA.

On the Pulse Fall 2013

A. J. Valente, J. Viikari, R. Prineas, 2013 .

Angiotensin II Upregulates Protein Phosphatase 2C&agr; and Inhibits AMP-Activated Protein Kinase Signaling and Energy Balance Leading to Skeletal Muscle Wasting

W. Mitch, P. Delafontaine, B. Chandrasekar, 2011, Hypertension.

Angiotensin II induced catabolic effect and muscle atrophy are redox dependent.

P. Delafontaine, B. Rezk, Tadashi Yoshida, 2011, Biochemical and biophysical research communications.

INSULIN‐LIKE GROWTH FACTOR I (IGF‐1) REDUCES LIPID OXIDATION AND FOAM CELL FORMATION VIA DOWNREGULATION OF 12/15‐LIPOXYGENASE

P. Delafontaine, S. Sukhanov, P. Snarski, 2014, Atherosclerosis.

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.

P. Delafontaine, B. Larson, D. Prockop, 2009, Cell stem cell.

Insulin-like Growth Factor-1 Increases Synthesis of Collagen Type I via Induction of the mRNA-binding Protein LARP6 Expression and Binding to the 5′ Stem-loop of COL1a1 and COL1a2 mRNA*

B. Stefanovic, P. Delafontaine, Y. Higashi, 2014, The Journal of Biological Chemistry.

Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging.

P. Delafontaine, Y. Higashi, H. Quevedo, 2014, Frontiers of hormone research.

Smooth Muscle Cell-Specific Insulin-Like Growth Factor-1 Overexpression in Apoe−/− Mice Does Not Alter Atherosclerotic Plaque Burden but Increases Features of Plaque Stability

P. Delafontaine, Y. Higashi, S. Sukhanov, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels.

P. Delafontaine, Yao‐Hua Song, Yangxin Li, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Insulin-Like Growth Factor-1 Receptor Activation Inhibits Oxidized LDL-Induced Cytochrome C Release and Apoptosis via the Phosphatidylinositol 3 Kinase/Akt Signaling Pathway

P. Delafontaine, Jie Du, Yao‐Hua Song, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Insulin-like growth factor binding protein-4 expression is decreased by angiotensin II and thrombin in rat aortic vascular smooth muscle cells.

P. Delafontaine, A. Anwar, A. A. Zahid, 2000, Arteriosclerosis, thrombosis, and vascular biology.

IRS-1 variant: A new risk factor for coronary artery disease?

P. Delafontaine, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Minocycline inhibits PDGF-BB-induced human aortic smooth muscle cell proliferation and migration by reversing miR-221- and -222-mediated RECK suppression.

P. Delafontaine, B. Chandrasekar, S. Mummidi, 2019, Cellular signalling.

Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration.

A. J. Valente, H. Iba, P. Delafontaine, 2014, Cellular signalling.

SM22&agr; (Smooth Muscle Protein 22-&agr;) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis

P. Delafontaine, Shin-ichiro Takahashi, B. Chandrasekar, 2018, Arteriosclerosis, thrombosis, and vascular biology.

Insulin-like growth factor-1 regulates glutathione peroxidase expression and activity in vascular endothelial cells: Implications for atheroprotective actions of insulin-like growth factor-1.

P. Delafontaine, B. Goodwin, Y. Higashi, 2013, Biochimica et biophysica acta.

Aging, atherosclerosis, and IGF-1.

P. Delafontaine, Y. Higashi, S. Sukhanov, 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

Insulin-Like Growth Factor I Prevents Cellular Aging via Activation of Mitophagy

P. Delafontaine, Z. Li, Y. Higashi, 2020, Journal of aging research.

Ct Values do not Predict SARS-CoV-2 Transmissibility in College Students

P. Delafontaine, R. Garry, Tony Y. Hu, 2021, The Journal of Molecular Diagnostics.

Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-α-induced cardiomyocyte death.

A. J. Valente, P. D. del Nido, P. Delafontaine, 2014, Journal of molecular and cellular cardiology.

Interleukin‐18/WNT1‐inducible signaling pathway protein‐1 signaling mediates human saphenous vein smooth muscle cell proliferation

A. J. Valente, P. Delafontaine, B. Chandrasekar, 2011, Journal of cellular physiology.

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Mehrad Amin Eskandari, J. F. Tinto, A. Capucci, 2018, Indian heart journal.

Angiotensin II Stimulates Transcription of Insulin-Like Growth Factor I Receptor in Vascular Smooth Muscle Cells: Role of Nuclear Factor-κB

T. Peng, P. Delafontaine, Jie Du, 2006 .

Protein LARP 6 Synthesis of Collagen Type I via Induction Insulin-like Growth Factor-1 Increases Molecular Bases of Disease :

B. Stefanovic, P. Delafontaine, Y. Higashi, 2014 .

Mammographically Detectable Breast Arterial Calcification and Atherosclerosis

P. Delafontaine, Neeraj Shah, J. Lafferty, 2014, Cardiology in review.

Special Issue on Controversies and Progress in IGF-1 and Aging Aging, Atherosclerosis, and IGF-1

P. Delafontaine, Y. Higashi, S. Sukhanov, 2012 .

Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress

S. N. Murthy, P. Delafontaine, V. Fonseca, 2009, Molecular and Cellular Biochemistry.

Angiotensin II suppresses autophagy and disrupts ultrastructural morphology and function of mitochondria in mouse skeletal muscle.

P. Delafontaine, Thaysa Ghiarone, B. Chandrasekar, 2019, Journal of applied physiology.

An Intronic Enhancer Element Regulates Angiotensin II Type 2 Receptor Expression during Satellite Cell Differentiation, and Its Activity Is Suppressed in Congestive Heart Failure*

P. Delafontaine, Tadashi Yoshida, 2016, The Journal of Biological Chemistry.

Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure

L. Navar, P. Delafontaine, Todd W. Markowski, 2021, International journal of molecular sciences.

Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study

A. Go, J. Roy, N. Bansal, 2015, Circulation. Heart failure.

Effect of Hurricane Katrina on incidence of acute myocardial infarction in New Orleans three years after the storm.

P. Delafontaine, S. Srivastav, Sudesh Srivastav, 2012, The American journal of cardiology.

Endothelial dysfunction: its role in hypertensive coronary disease

P. Delafontaine, I. Bolad, 2005, Current opinion in cardiology.

Digital Plethysmography and Arginine Metabolism in Prehypertension—Effect of Nebivolol Therapy

P. Delafontaine, T. Giles, L. Roffidal, 2015, Journal of clinical hypertension.

51 PREDICTORS OF LEFT VENTRICULAR DILATATION IN YOUNG ADULTS: THE BOGALUSA HEART STUDY

P. Delafontaine, S. Srinivasan, G. Berenson, 2005, Journal of Investigative Medicine.

A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study.

A. Go, Mahboob Rahman, M. Keane, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Skeletal muscle molecular alterations precede whole-muscle dysfunction in NYHA Class II heart failure patients

P. Delafontaine, M. Godard, Yao‐Hua Song, 2012, Clinical interventions in aging.

Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and function

P. Delafontaine, Tadashi Yoshida, S. Sukhanov, 2014, Skeletal Muscle.

Elevation of cardiovascular risk by non-steroidal anti-inflammatory drugs.

P. Delafontaine, A. Anwar, I. Anwar, 2015, Trends in cardiovascular medicine.

Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.

M. Zhan, E. Soliman, P. Delafontaine, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure.

A. Go, M. Keane, Jiang He, 2011, Journal of cardiac failure.

Estrogen regulates insulin-like growth factor 1, platelet-derived growth factor A and B, and their receptors in the vascular wall

P. Delafontaine, H. Savolainen-Peltonen, P. Häyry, 2004, Transplantation.

Gamma-Irradiation Markedly Inhibits the Hydrated Collagen Gel Contraction by Arterial Smooth Muscle Cells

P. Delafontaine, P. Delafontaine, P. Keller, 2001, Journal of Investigative Medicine.

Effect of Hurricane Katrina on chronobiology at onset of acute myocardial infarction during the subsequent three years.

P. Delafontaine, Thomas A. Turnage, A. Irimpen, 2013, The American journal of cardiology.

ACUTE MYOCARDIAL INFARCTION BEFORE AND AFTER THE STORM: HURRICANE KATRINA

P. Delafontaine, I. Hameed, S. Srivastav, 2011 .

Oxidized Low-Density Lipoprotein Is Associated With Apoptosis of Vascular Smooth Muscle Cells in Human Atherosclerotic Plaques

A. Kalangos, P. Delafontaine, M. Brink, 2000, Circulation.

Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty.

William Wijns, Martyn Thomas, Wolfgang Sauerwein, 2001 .

Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.

W. Mitch, P. Delafontaine, Y. Higashi, 2013, The international journal of biochemistry & cell biology.

Recent Publications From Our Faculty and Fellows

P. Delafontaine, R. A. Clark, C. Raia, 2012 .

β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.

P. Delafontaine, B. Chandrasekar, S. Mummidi, 2012, Journal of molecular and cellular cardiology.

Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation.

P. Delafontaine, B. Chandrasekar, S. Mummidi, 2010, American journal of physiology. Heart and circulatory physiology.